Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Open Access
- 19 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
Abstract
Alzheimer disease (AD) is a chronic neurodegenerative disease that accounts for 60–70% of dementia and is the sixth leading cause of death in the United States. The pathogenesis of this debilitating disorder is still not completely understood. New insights into the pathogenesis of AD are needed in order to develop novel pharmacologic approaches. In recent years, numerous studies have shown that insulin resistance plays a significant role in the development of AD. Over 80% of patients with AD have type II diabetes (T2DM) or abnormal serum glucose, suggesting that the pathogenic mechanisms of insulin resistance and AD likely overlap. Insulin resistance increases neuroinflammation, which promotes both amyloid β-protein deposition and aberrant tau phosphorylation. By increasing production of reactive oxygen species, insulin resistance triggers amyloid β-protein accumulation. Oxidative stress associated with insulin resistance also dysregulates glycogen synthase kinase 3-β (GSK-3β), which leads to increased tau phosphorylation. Both insulin and amyloid β-protein are metabolized by insulin degrading enzyme (IDE). Defects in this enzyme are the basis for a strong association between T2DM and AD. This review highlights multiple pathogenic mechanisms induced by insulin resistance that are implicated in AD. Several pharmacologic approaches to AD associated with insulin resistance are presented.Keywords
This publication has 139 references indexed in Scilit:
- Antioxidant Therapies for Alzheimer's DiseaseOxidative Medicine and Cellular Longevity, 2012
- Ablation of TNF-RI/RII Expression in Alzheimer's Disease Mice Leads to an Unexpected Enhancement of Pathology: Implications for Chronic Pan-TNF-α Suppressive Therapeutic Strategies in the BrainThe American Journal of Pathology, 2011
- Amyloid Precursor Protein Processing and Alzheimer's DiseaseAnnual Review of Neuroscience, 2011
- Oxidative stress, insulin signaling, and diabetesFree Radical Biology & Medicine, 2011
- Review Article: Genetics of Alzheimer DiseaseJournal of Geriatric Psychiatry and Neurology, 2010
- Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III StudyDementia and Geriatric Cognitive Disorders, 2010
- Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading EnzymeOnline Journal of Public Health Informatics, 2009
- JNK regulates APP cleavage and degradation in a model of Alzheimer's diseaseNeurobiology of Disease, 2009
- Chapter 22 Structure, Function, and Regulation of Insulin‐Degrading EnzymeVitamins and Hormones, 2009
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseBMC Neuroscience, 2008